The American Journal of Managed Care

Sequencing by Prior Exposure: How the mCRPC Treatment Map Has Changed

The mCRPC section's reorganization by prior treatment exposure reflects how ARPI and docetaxel use in the hormone-sensitive ...

Dr. Ajay Bhatnagar on Why Brachytherapy Is Central to Understanding Cost, Outcomes, and Decision-Making in Prostate Cancer Care

From his perspective, one of the most persistent misconceptions in prostate cancer care relates to how patients interpret ...

Johnson & Johnson reports Q1 2026 results, raises 2026 outlook

Johnson & Johnson (NYSE: JNJ) today announced results for first-quarter 2026. "Johnson & Johnson had a strong start to 2026 and is delivering on its promise for a year of accelerated growth and impact ...
The American Journal of Managed Care

Radium-223 in the Modern Era: Patient Selection and Sequencing

Bone-only, osteoblastic disease and the absence of prior ARPI exposure define the optimal radium-223 candidate, while ...
Healio

‘Why do we do this?’: Sooner not better for CDK4/6 inhibitors in advanced breast cancer

As clinicians celebrated results of the PALOMA-2 study at ASCO Annual Meeting in 2016, Gabe S. Sonke, MD, PhD, had a question ...